The 177.5 share purchase was part of a larger buy

The 177.5 share purchase was part of a larger buy by a friend of mine It reflected the bright future we both see for SCRC. We had discussed the probable capacity expansion at MAV, the possibility of Hong Kong ,Taiwon and China purchases of RapiMed after all the red tape is cleared and the huge potential growth at PIMD when additional state licenses are obtained. Also the recent arrangements made with pharmacy chains like United Apothecary should aid SCRC's growth. Finally we look forward to September when we see the company possibly being cash-flow positive and being in the black. Who knows, we soon may see a 100 million run rate. Go SCRC Go !!!